The creation of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, requires a complex multi-step synthetic process. Initial routes focused on protein portion coupling, utilizing solid-phase https://nicolasbdwt809868.blogadvize.com/49158965/synthesis-and-investigation-uses-of-retatrutide